These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11216965)

  • 1. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
    van den Heuvel AF; Dunselman PH; Kingma T; Verhorst P; Boomsma F; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2001 Feb; 37(2):470-4. PubMed ID: 11216965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction].
    Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M
    Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina.
    Kaski JC; Rosano G; Gavrielides S; Chen L
    J Am Coll Cardiol; 1994 Mar; 23(3):652-7. PubMed ID: 8113548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential proischemic effect of early enalapril in hypotension-prone patients with acute myocardial infarction. The CONSENSUS II Holter Substudy Group.
    Søgaard P; Thygesen K
    Cardiology; 1997; 88(3):285-91. PubMed ID: 9129851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of captopril on exercise tolerance in patients with chronic stable angina pectoris and normal left ventricular function.
    Steffensen R; Grande P; Madsen JK; Rasmussen S; Haunsø S
    Cardiology; 1995; 86(6):445-50. PubMed ID: 7585753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV; Carstensen S; Caidahl K; Nilsen DW; Edner M; Lindvall K; Snapinn SM; Berning J
    Am Heart J; 1996 Jul; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
    Romano M; Cardei S; de Arcangelis E; Monteforte I; Capaldo M; Muto P; Marchegiano R; Kilama MO; Condorelli M
    Am Heart J; 1997 Mar; 133(3):268-72. PubMed ID: 9060793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
    Dunselman PH;
    Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
    González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
    Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.
    Ikram H; Low CJ; Shirlaw TM; Foy SG; Crozier IG; Richards AM; Khurmi NS; Horsburgh RJ
    Br Heart J; 1994 Jan; 71(1):30-3. PubMed ID: 8297690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function.
    Bartels GL; van den Heuvel FM; van Veldhuisen DJ; van der Ent M; Remme WJ
    Am J Cardiol; 1999 Feb; 83(3):332-6. PubMed ID: 10072218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
    J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.
    Simon J; Gibbs R; Crean PA; Mockus L; Wright C; Sutton GC; Fox KM
    Br Heart J; 1989 Aug; 62(2):112-7. PubMed ID: 2548548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
    Young JB
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study].
    Odenthal HJ; Thürmann P; Wiechmann HW; Josephs W; Lenga P
    Z Kardiol; 1991 Jun; 80(6):392-6. PubMed ID: 1926985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.